Treatment Formats and Cost Considerations When pursuing treatment in the Rockville area, it is helpful to distinguish between the two main types of ketamine therapies, as their financial models vary considerably. Off-label treatments, such as IV, IM, and sublingual ketamine, are generally not covered by health insurance. Because these formulations are compounded and administered off-label for psychiatric use, patients usually pay out-of-pocket. The FDA has issued a warning regarding these preparations; you can read more here: FDA warns patients and health care providers about potential risks associated with compounded ketamine products.

In contrast, Spravato (esketamine) is an FDA-approved nasal spray indicated for specific adult depression conditions. Because of its approved status, Spravato is often eligible for insurance coverage, though this typically requires an extensive prior authorization process to verify that other depression treatments have been unsuccessful.

Planning Your Medical Budget Since neither insurers nor clinics can guarantee coverage in advance, patients should request a comprehensive written estimate before beginning a treatment cycle. When evaluating the total financial impact, remember to factor in logistical expenses. Repeated visits are required for both off-label ketamine and Spravato. Patients must account for the cost of transportation, potential lost wages due to time away from work, and any travel or lodging expenses if they choose a clinic outside of Montgomery County.

Logistical Challenges and Travel Ketamine and Spravato therapies begin with a thorough psychiatric assessment and require a commitment to repeated visits over several weeks. Environmental and logistical factors can complicate this schedule. In Maryland, winter snow and ice, severe storms, Marylandpolis traffic and rural travel distances may affect travel to your chosen clinic. Telehealth services are frequently utilized for initial consultations and ongoing assessments, but they cannot replace the required on-site clinical administration.

Safety Protocols and Administration Stringent safety regulations apply to these treatments. Spravato must be administered exclusively in a certified healthcare setting. Patients undergo a minimum of two hours of clinical observation following the dose. Afterward, you are prohibited from driving until the next day, following a restful sleep. A responsible adult must be available to drive you home from the clinic.

Spravato is never dispensed for home use. While some clinicians prescribe compounded ketamine for at-home administration, these products are not FDA-approved for psychiatric care. The FDA strongly warns against the risks of using compounded ketamine without on-site clinical monitoring. If you or a loved one are experiencing a mental health emergency, please contact the 988 Suicide & Crisis Lifeline by choosing to call or text 988, available 24/7. In life-threatening emergencies, always dial 911.